At 6 years, transcatheter aortic valve replacement (TAVR) appears to rival surgery for major adverse events in low-risk patients with severe aortic stenosis, but it may come at the cost of more ...
CHICAGO, IL — The largest-ever review of transcatheter aortic-valve replacement (TAVR) procedures for failed bioprosthetic valves suggests that TAVR could play a key role in solving a problem that ...
Bronson Methodist Hospital and Bronson Advanced Cardiac Healthcare are celebrating 13 years of performing transcatheter aortic valve replacement (TAVR), a minimally invasive procedure that has given ...
Five-year data from the PARTNER 3 trial showed that among low-risk patients with severe, symptomatic aortic stenosis, outcomes were similar among patients who had undergone transcatheter aortic-valve ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. At 7 years, there was no difference in clinical outcomes ...
Google searches for transcatheter aortic valve replacement surged among laypersons when pivotal trials were published, ...
Two observational studies indicate GLP-1 receptor agonists may reduce complications after transcatheter aortic valve replacement (TAVR) and carotid artery stenting (CAS). Post-TAVR tirzepatide use was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results